News | Treatment Planning | February 18, 2022

Montérégie Integrated Cancer Center (CICM), which is part of the Charles-Le Moyne hospital in Longueuil in Quebec in Canada, has placed an order for additional RayStation licenses as well as upgrades to the system which includes advanced treatment planning functionality

RaySearch has a strong position in the radiotherapy market in Canada with a market share of approximately 25 percent. Charles-Le Moyne hospital has been a RayStation customer since 2018.

February 18, 2022 — RaySearch has a strong position in the radiotherapy market in Canada with a market share of approximately 25 percent. Charles-Le Moyne hospital has been a RayStation customer since 2018. With the planned expansion, the cancer clinic will now fully replace their former treatment planning system with RayStation for all of their radiation oncology services, which today includes eight linear accelerators. Further, the clinic has added new and advanced technology to the order, including multi-criteria optimization, dose tracking, adaptive planning and TomoTherapy planning.

Johan Löf, founder and CEO, RaySearch, says: “RaySearch is always pleased when a customer has experienced our products and services, and then chooses to expand their utilization based on that success. We appreciate their trust in us, as well as their dedication to their patients, and expect that our excellent relationship with the team at Charles-Le Moyne will continue for many years.”

About Charles-Le Moyne hospital

Cancer treatment at Charles-Le Moyne hospital is provided by the team at Montérégie Integrated Cancer Center (CICM). The CICM is a center of excellence and reference in the fight against cancer recognized as a leader in Montérégie. Each year, the CICM receives some 48,000 visits and the center treats nearly 30 types of cancer.

For more information: www.raysearchlabs.com


Related Content

News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 09, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now